{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:39:35Z","timestamp":1781789975654,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.prp.2025.155910","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T08:00:45Z","timestamp":1741766445000},"page":"155910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["FCGR1A(CD64) expression on monocyte subsets and FIL1Z(IL-37) serum level as biomarkers of rheumatoid arthritis activity: A case controlled study and in silico analysis"],"prefix":"10.1016","volume":"269","author":[{"given":"Entsar R.","family":"Mokhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Aly","family":"Abd El-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neama R.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Elhakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia A.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Fekry","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab Abd Elfattah","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammar Ahmed","family":"Kasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Elhadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Mohamed M.","family":"Ali Abd El Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Sobhy Mahmoud","family":"Rezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-107X","authenticated-orcid":false,"given":"Nadia M.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekmat M.","family":"El Magdoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155910_bib1","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030485","article-title":"Peripheral blood B-cell subsets frequency and distribution and the BSF-2(IL-6) to CSIF:TGIF(IL-10) ratio as severity-associated signatures in primary open-angle glaucoma: a case-controlled study","volume":"12","author":"Mokhtar","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib3","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/rheumatology\/keaa518","article-title":"The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis","volume":"60","author":"Prajzlerov\u00e1","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"16","key":"10.1016\/j.prp.2025.155910_bib4","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"issue":"1-3","key":"10.1016\/j.prp.2025.155910_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol. Res"},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib6","first-page":"2703","article-title":"Overexpression of CD64 on CD14(++)CD16(-) and CD14(++)CD16(+) monocytes of rheumatoid arthritis patients correlates with disease activity","volume":"16","author":"Luo","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"11","key":"10.1016\/j.prp.2025.155910_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/intimm\/dxz036","article-title":"Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis","volume":"31","author":"Hirose","year":"2019","journal-title":"Int Immunol."},{"key":"10.1016\/j.prp.2025.155910_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.33696\/immunology.5.184","article-title":"Macrophages in bone and synovial inflammation in rheumatoid arthritis","volume":"5","author":"Jalalvand","year":"2023","journal-title":"J. Cell. Immunol."},{"key":"10.1016\/j.prp.2025.155910_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","article-title":"Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis","volume":"65","author":"Rana","year":"2018","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2025.155910_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-020-02308-7","article-title":"CD14(+)CD16(-) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK","volume":"22","author":"Xue","year":"2020","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.prp.2025.155910_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","article-title":"Osteoclast differentiation in rheumatoid arthritis","volume":"47","author":"Yokota","year":"2024","journal-title":"Immunol. Med"},{"issue":"7","key":"10.1016\/j.prp.2025.155910_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat. Rev. Rheuma"},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib13","first-page":"540","article-title":"Increased circulating CD14brightCD16+\u2009intermediate monocytes are regulated by TNF-\u03b1 and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis","volume":"36","author":"Tsukamoto","year":"2018","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.prp.2025.155910_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113126","article-title":"Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis","volume":"151","author":"Ben Mrid","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1189\/jlb.3MA0616-287R","article-title":"Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells","volume":"101","author":"Rudloff","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.prp.2025.155910_bib16","doi-asserted-by":"crossref","first-page":"1278521","DOI":"10.3389\/fimmu.2023.1278521","article-title":"Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process","volume":"14","author":"Gu","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.155910_bib17","article-title":"Detection of IL-37 in peripheral blood of patients with rheumatoid arthritis and its clinical significance","volume":"17","author":"Zhang","year":"2019"},{"issue":"6","key":"10.1016\/j.prp.2025.155910_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/1756-185X.13539","article-title":"Elevated expression of interleukin-37 in patients with rheumatoid arthritis","volume":"22","author":"Yuan","year":"2019","journal-title":"Int J. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4078\/jrd.2020.27.3.152","article-title":"Circulating interleukin-37 levels in rheumatoid arthritis and systemic lupus erythematosus and their correlations with disease activity: a meta-analysis","volume":"27","author":"Lee","year":"2020","journal-title":"J. Rheum. Dis."},{"key":"10.1016\/j.prp.2025.155910_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2147\/IJGM.S309436","article-title":"Correlation between level of interleukin-37 and rheumatoid arthritis progression","volume":"14","author":"Zhu","year":"2021","journal-title":"Int J. Gen. Med"},{"key":"10.1016\/j.prp.2025.155910_bib21","unstructured":"Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D.G., & Newman, T.B., Designing clinical research. 4th Edition ed. 2013: Lippincott Williams and Wilkins."},{"issue":"5","key":"10.1016\/j.prp.2025.155910_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095346","article-title":"Plasma levels of IL-37 and correlation with TNF-\u03b1, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"_6","key":"10.1016\/j.prp.2025.155910_bib23","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology"},{"issue":"5 101","key":"10.1016\/j.prp.2025.155910_bib24","article-title":"The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis","volume":"34","author":"van Riel","year":"2016","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.prp.2025.155910_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2016.03.034","article-title":"Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study","volume":"107","author":"Amoruso","year":"2016","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.prp.2025.155910_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-016-1216-6","article-title":"CD14(bright)CD16+\u2009intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis","volume":"19","author":"Tsukamoto","year":"2017","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.prp.2025.155910_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark. Res"},{"key":"10.1016\/j.prp.2025.155910_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-015-0901-1","article-title":"Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists","volume":"18","author":"Lacerte","year":"2016","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1529-0131(200104)44:4<739::AID-ANR129>3.0.CO;2-O","article-title":"Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease","volume":"44","author":"Salmon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.prp.2025.155910_bib30","first-page":"77","article-title":"Expression and significance of CD64 on monocyte subsets from patients with rheumatoid arthritis","volume":"12","author":"Huang","year":"2018","journal-title":"Chinese J. Immunol."},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib31","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.4049\/jimmunol.0801683","article-title":"Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses","volume":"183","author":"Tanaka","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2025.155910_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13075-023-03147-y","article-title":"CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis","volume":"25","author":"Theeuwes","year":"2023","journal-title":"Arthritis Res Ther."},{"issue":"9","key":"10.1016\/j.prp.2025.155910_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137474","article-title":"Elevated membrane and soluble CD64: a novel marker reflecting altered Fc\u03b3R function and disease in early rheumatoid arthritis that can be regulated by anti-rheumatic treatment","volume":"10","author":"Matt","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.prp.2025.155910_bib34","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10753-015-0188-z","article-title":"Anti-citrullinated protein antibodies induce macrophage subset disequilibrium in RA patients","volume":"38","author":"Zhu","year":"2015","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152382","article-title":"IL-37 alleviates TNF-\u03b1-induced pyroptosis of rheumatoid arthritis fibroblast-like synoviocytes by inhibiting the NF-\u03baB\/GSDMD signaling pathway","volume":"228","author":"Ren","year":"2023","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/jir.2013.0059","article-title":"The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus","volume":"34","author":"El Mesallamy","year":"2014","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.prp.2025.155910_bib38","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.2147\/JIR.S474879","article-title":"Role of IL-1 family cytokines IL-36, IL-37, IL-38 in osteoarthritis and rheumatoid arthritis: a comprehensive review","volume":"17","author":"Xu","year":"2024","journal-title":"J. Inflamm. Res"},{"issue":"4","key":"10.1016\/j.prp.2025.155910_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nold-Petry","year":"2015","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.prp.2025.155910_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1389450121666200429114926","article-title":"IL-37 as a potential biotherapeutics of inflammatory diseases","volume":"21","author":"Bai","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.prp.2025.155910_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106391","article-title":"A new target for the treatment of inflammatory bowel disease: interleukin-37","volume":"83","author":"Jia","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.prp.2025.155910_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.gene.2013.11.042","article-title":"Interaction between TGF-\u03b21 (869C\/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis","volume":"536","author":"Hussein","year":"2014","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.prp.2025.155910_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/AZMJ.AZMJ_55_19","article-title":"Study of the effect of interleukin-6 gene polymorphism in patients with rheumatoid arthritis","volume":"17","author":"Sedira","year":"2019","journal-title":"Al-Azhar Assiut Med. J."},{"issue":"2","key":"10.1016\/j.prp.2025.155910_bib44","article-title":"Abualfa, S.M., et a., Relationship between serum levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule-3 and Systemic Lupus Erythematosus","volume":"4","year":"2022","journal-title":"Al-Azhar Un. J. Res. Stud."},{"issue":"9","key":"10.1016\/j.prp.2025.155910_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.58675\/2682-339X.2646","article-title":"Assessment of serum catestatin levels in rheumatoid arthritis patients with correlation to disease activity","volume":"5","author":"Abd-El Aziz","year":"2024","journal-title":"Al-Azhar Int. Med. J."},{"key":"10.1016\/j.prp.2025.155910_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154960","article-title":"Hsa-miR-21\u20135p reflects synovitis and tenosynovitis components of musculoskeletal ultrasonography Seven-joint scores in rheumatoid arthritis disease and predicts the disease flare","volume":"253","author":"Hammad","year":"2024","journal-title":"Pathol. -Res. Pract."},{"issue":"3","key":"10.1016\/j.prp.2025.155910_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.12659\/MSM.881453","article-title":"Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure","volume":"17","author":"Hamdy","year":"2011","journal-title":"Med Sci. Monit."},{"issue":"13","key":"10.1016\/j.prp.2025.155910_bib48","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/nu15132830","article-title":"Effect of vitamin D supplementation on primary dysmenorrhea: A systematic review and meta-analysis of randomized clinical trials","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:47:16Z","timestamp":1749221236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":48,"alternative-id":["S0344033825001025"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155910","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FCGR1A(CD64) expression on monocyte subsets and FIL1Z(IL-37) serum level as biomarkers of rheumatoid arthritis activity: A case controlled study and in silico analysis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155910"}}